Literature DB >> 9740708

Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.

E J Kaplan1, T A Caputo, P U Shen, R I Sassoon, R A Soslow.   

Abstract

OBJECTIVE: We report an occult primary papillary serous carcinoma of the endocervix that was encountered in a woman whose mother and identical twin sister died of papillary serous carcinomas (PSCs) of the peritoneum and ovary, respectively.
METHODS: The medical records and the histologic material belonging to the patient, her sister, and her mother were reviewed.
RESULTS: The cervical PSC was histologically similar to the peritoneal and ovarian carcinomas. The patient has recurred with peritoneal carcinomatosis 24 months following surgery and postoperative radiotherapy and chemotherapy.
CONCLUSIONS: Primary papillary serous carcinoma of the cervix is a very rare adenocarcinoma variant; there have been approximately 30 such cases reported, and, to our knowledge, this is the first documented case of familial peritoneal/ovarian/uterine papillary serous carcinoma. The prophylaxis achieved through bilateral oophorectomy in individuals with a family history of ovarian cancer does not address the risk of PSCs arising in the uterus, cervix, or peritoneum. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9740708     DOI: 10.1006/gyno.1998.5046

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.

Authors:  Murray Joseph Casey; Agnes B Colanta
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

Review 3.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

4.  Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Authors:  Murray Joseph Casey; Chhanda Bewtra; Henry T Lynch; Carrie Snyder; Mark Stacy; Patrice Watson
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

5.  Advanced papillary serous carcinoma of the uterine cervix: a case with a remarkable response to paclitaxel and carboplatin combination chemotherapy.

Authors:  Masashi Ueda; Masafumi Koshiyama; Ayaka Yamaguchi; Shingo Ukita; Masayo Ukita; Kenji Hishikawa; Kazuyo Kakui; Tomoko Kim; Tomoyuki Shirase
Journal:  Rare Tumors       Date:  2011-12-20

6.  Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs.

Authors:  Shoko Kitade; Kazuya Ariyoshi; Kenichi Taguchi; Shoji Maenohara; Yui Tomita; Kenzo Sonoda; Masao Okadome; Toshiaki Saito
Journal:  J Obstet Gynaecol Res       Date:  2019-10-22       Impact factor: 1.730

7.  BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study.

Authors:  Sarah J Kitson; Cemsel Bafligil; Neil A J Ryan; Fiona Lalloo; Emma R Woodward; Richard D Clayton; Richard J Edmondson; James Bolton; Emma J Crosbie; D Gareth Evans
Journal:  Eur J Cancer       Date:  2020-07-19       Impact factor: 9.162

8.  So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature.

Authors:  Ruth Gabriela Herrera Gómez; Delfyne Hastir; Aikaterini Liapi; Ana Dolcan; Fernanda G Herrera; Patrice Mathevet; Apostolos Sarivalasis
Journal:  Case Rep Oncol       Date:  2021-12-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.